探讨作为心血管疾病治疗点的硫素相互作用蛋白 (TXNIP)
Shrutika Date1, Lokesh Kumar Bhatt1
1Department of Pharmacology, SVKM's Dr. Bhanuben Nanavati College of Pharmacy, Vile Parle (W), Mumbai, India.
Archiv der Pharmazie
|August 25, 2025
概括
硫素相互作用蛋白 (TXNIP) 通过促进氧化应激和炎症驱动心血管疾病. 针对TXNIP提供了一种有前途的治疗策略,以缓解心血管疾病的进展并改善患者的治疗结果.
科学领域:
- 生物化学
- 分子生物学
- 心脏病学
背景情况:
- 心血管疾病是全球主要的死亡原因.
- 氧化应激是心血管疾病发病的一个关键因素.
- 铁素相互作用蛋白 (TXNIP) 是一个关键的氧化还原调节剂,涉及到心血管疾病.
研究的目的:
- 审查TXNIP在心血管疾病进展中的作用.
- 阐明TXNIP导致心血管疾病的分子机制.
- 探索TXNIP作为潜在的心血管疾病治疗点.
主要方法:
- 对TXNIP在心血管疾病中的参与进行文献审查.
- 对TXNIP在氧化应激和炎症中的调节功能进行分析.
- 在心血管环境中检查TXNIP影响的信号通路.
主要成果:
- TXNIP作为一种促氧化剂,破坏抗氧化功能并引起氧化还原失衡.
- TXNIP激活NLRP3炎症酶,导致IL-1β和IL-18的释放和炎症.
- 通过改变TRX/ ASK1相互作用,TXNIP可以调节亡和亡.
- TXNIP 调节关键信号通路,包括 TXNIP/SIRT1/FOXO1,TXNIP/Redd1,TLR4/NF-κB/TXNIP/NLRP3,以及NRF2/TXNIP.
结论:
- 在心血管疾病中,TXNIP是氧化应激和炎症的中心媒介.
- 在血管损伤,内皮功能障碍和细胞死亡途径中发挥重要作用.
- 针对TXNIP提供了治疗心血管疾病的潜在途径.
相关概念视频
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.8K
01:26Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
505
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505
01:26Heart Failure Drugs: Inotropic Agents
717
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
717
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
256
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
256
01:14Myocarditis III: Medical Management
15
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
15